Summary
Bipolar disorder (BPD) is a chronic or recurrent psychological disorder that affects more than 1% of the global population[1]. As shown in Figure 1, it is characterized by fluctuations in mood and energy[2] and marked by episodes of mania (great excitement, euphoria), hypomania (persistently elevated and/or irritable mood), and depression, BPD negatively impacts[3] quality of life and overall functioning. With its far-reaching impact on the lives of those who have it, BPD results in the highest suicide rate[4] among mood-related disorders, with a greater risk of suicide attempts during depressive episodes.
Examine Database: Bipolar Disorder Symptoms
Intervention | Grade | Effect | Detail |
---|---|---|---|
Fish Oil | B | ||
Inositol | D | ||
Ashwagandha | C | ||
Chromium | |||
CDP-Choline | |||
Uridine |
Research FeedRead all studies
References
Examine Database References
- Ashwagandha - Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal RRandomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorderJ Clin Psychiatry.(2013 Nov)
- CDP-Choline - Brown ES, Gorman AR, Hynan LSA randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependenceJ Clin Psychopharmacol.(2007 Oct)
- Chromium - Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, Dittmann S, Grunze HA 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorderJ Clin Psychopharmacol.(2007 Feb)
- Fish Oil - Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM, Renshaw PFOmega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorderAm J Psychiatry.(2004 Oct)
- Inositol - Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJInositol as an add-on treatment for bipolar depressionBipolar Disord.(2000 Mar)
- Uridine - Douglas G. Kondo, M.D, Young-Hoon Sung, M.D, Tracy L. Hellem, B.S, Kristen K. Delmastro, B.S, Eun-Kee Jeong, Ph.D, Namkug Kim, Ph.D, Xianfeng Shi, Ph.D, and Perry F. RenshawOpen-Label Uridine for Treatment of Depressed Adolescents with Bipolar DisorderJournal of Child and Adolescent Psychopharmacology.()
- Fish Oil - Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RMDouble-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderBiol Psychiatry.(2006 Nov 1)
- Fish Oil - Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA Jr, Cohen BMOmega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trialJ Clin Psychopharmacol.(2012 Oct)
- Inositol - Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GSTreatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidoneAm J Psychiatry.(2006 Feb)
- Fish Oil - Frangou S, Lewis M, McCrone PEfficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled studyBr J Psychiatry.(2006 Jan)
- Fish Oil - Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LBOmega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trialArch Gen Psychiatry.(1999 May)